Skip to main content

Virtus Fund Advisers, LLC

SEC CIK
0001319111
Latest filing
Feb 14, 2025

AMRX holding history

Amneal Pharmaceuticals, Inc. in every 13F filed by Virtus Fund Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AMRX overviewAll 13F holders of AMRXFull Q4 2024 holdings

Shares (Q3 2023)
0
Sold out in Q3 2023
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q1 2023
Holdings of AMRX by Virtus Fund Advisers, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20230$00.0%−6,941−100.0%Sold outHolders
Q2 20236,941$21.5K0.2%00.0%UnchangedHolders
Q1 20236,941$9.65K0.1%+6,941NewHolders